Search

Displaying results 21 - 30 of 78 in total
  1. Indication

    Unresectable, locally advanced HER2-positive Adenocarcinoma of the Stomach

    go.drugbank.com/conditions/DBCOND0144311
    Drugs: Pembrolizumab
  2. Indication

    Unresectable, locally recurrent Triple Negative Breast Cancer

    go.drugbank.com/conditions/DBCOND0144330
    Drugs: Pembrolizumab
  3. Indication

    Unresectable, recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    go.drugbank.com/conditions/DBCOND0144293
    Drugs: Pembrolizumab
  4. Indication

    FIGO 2014 Stage III-IVA Cervical Cancer

    go.drugbank.com/conditions/DBCOND0163323
    Drugs: Pembrolizumab
  5. Indication

    Stage IB Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0028480
    Drugs: Pembrolizumab
  6. Indication

    Stage IIB Melanoma

    go.drugbank.com/conditions/DBCOND0028887
    Drugs: Pembrolizumab
  7. Indication

    High risk, early Triple Negative Breast Cancer

    go.drugbank.com/conditions/DBCOND0144329
    Drugs: Pembrolizumab
  8. Indication

    Locally advanced Unresectable Biliary Tract Cancer

    go.drugbank.com/conditions/DBCOND0162416
    Drugs: Pembrolizumab
  9. Indication

    Metastatic HER2-positive Adenocarcinoma of the Stomach

    go.drugbank.com/conditions/DBCOND0144313
    Drugs: Pembrolizumab
  10. Indication

    Metastatic Mismatch repair deficient (dMMR) solid tumors

    go.drugbank.com/conditions/DBCOND0144303
    Drugs: Pembrolizumab